Novo Nordisk signs deal for monthly GLP-1 agonist Novo Nordisk is putting down up to US$362m to tap into Ascendis TransCon technology for treatments in metabolic and cardiovascular diseases
no completed human clinical trials have been published
While most manufacturers use single phospholipid formulations or simple mixing methods, LiposoMax utilizes a proprietary multi -phospholipid and fatty acid complex that creates what Dr
BioTech USA L-Carnitine 1000 mg 60 tablets L-carnitine tablets containing 1000 mg of l-carnitine tartrate
as of May 2026 is clinical trial enrollment FDA-approved alternatives exist (semaglutide, tirzepatide) with established compounding and dosing pathways and substantial clinical data Self-sourcing research peptides for human use is not safe and carries identity, purity, and contamination risks If you are a clinician: Patient questions about retatrutide source verification are increasing
According to the FDA and KDIGO-ADA 2022 guidelines, liraglutide, semaglutide, and tirzepatide generally do not require dose adjustments in CKD patients